pUC CBA-SpCas9.EF1a-BFP.sgLMNA Citations (4)

Originally described in: Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.
Arnoult N, Correia A, Ma J, Merlo A, Garcia-Gomez S, Maric M, Tognetti M, Benner CW, Boulton SJ, Saghatelian A, Karlseder J Nature. 2017 Sep 20;549(7673):548-552. doi: 10.1038/nature24023. PubMed Journal

---

Articles Citing pUC CBA-SpCas9.EF1a-BFP.sgLMNA

Articles
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death. Scott DE, Francis-Newton NJ, Marsh ME, Coyne AG, Fischer G, Moschetti T, Bayly AR, Sharpe TD, Haas KT, Barber L, Valenzano CR, Srinivasan R, Huggins DJ, Lee M, Emery A, Hardwick B, Ehebauer M, Dagostin C, Esposito A, Pellegrini L, Perrior T, McKenzie G, Blundell TL, Hyvonen M, Skidmore J, Venkitaraman AR, Abell C. Cell Chem Biol. 2021 Jun 17;28(6):835-847.e5. doi: 10.1016/j.chembiol.2021.02.006. Epub 2021 Mar 3. PubMed
Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Lee M, Shorthouse D, Mahen R, Hall BA, Venkitaraman AR. Nucleic Acids Res. 2021 Jun 4;49(10):5588-5604. doi: 10.1093/nar/gkab308. PubMed
Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions. Kumbhar R, Sanchez A, Perren J, Gong F, Corujo D, Medina F, Devanathan SK, Xhemalce B, Matouschek A, Buschbeck M, Buck-Koehntop BA, Miller KM. J Cell Biol. 2021 Jul 5;220(7). pii: 212163. doi: 10.1083/jcb.202006149. Epub 2021 May 18. PubMed
Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer. Zhu Y, Liu Z, Gui L, Yun W, Mao C, Deng R, Yao Y, Yu Q, Feng J, Ma H, Bao W. NPJ Breast Cancer. 2023 May 8;9(1):34. doi: 10.1038/s41523-023-00540-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.